Hemostatic Agents and Tissue Sealants Market 2022: Industry Size, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2028
Hemostatic Agents and Tissue Sealants Market 2022: Industry Size, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2028
The research report on ‘Hemostatic Agents and Tissue Sealants Market’ provides a workplan for stakeholders for the estimated timeframe of -. To elaborate, it offers valid predictions for the size, shares, and growth patterns of this domain over the projected timeline by assessing the past records and present business trends.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Hemostats and sealants are medical devices used to cease bleeding and hemorrhage caused by injuries and surgical procedures. The market is expected to witness lucrative growth over the next seven years owing to an increase in demand supported by the rising surgery volumes.
This report aims to provide a comprehensive presentation of the global market for Hemostatic Agents and Tissue Sealants study by Market Intellix gives insights concerning the market elements influencing the market, Market scope, Market division, and overlays shadow upon the leading market players featuring the positive cutthroat scene and patterns beating the years.
Global Hemostatic Agents and Tissue Sealants Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Hemostatic Agents and Tissue Sealants Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Hemostatic Agents and Tissue Sealants companies in 2021 (%)
The global Hemostatic Agents and Tissue Sealants market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hemostasis Agents Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hemostatic Agents and Tissue Sealants include Johnson & Johnson, Baxter, C R Bard, B Braun, Gelita, Integra Life Sciences, Advance Medical Solution, Pfizer and CSL Behring, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
The study provides the Hemostatic Agents and Tissue Sealants manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Segmental Outline:
Global Hemostatic Agents and Tissue Sealants Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hemostatic Agents and Tissue Sealants Market Segment Percentages, by Type, 2021 (%)
Hemostasis Agents
Tissue Sealing Agents
Global Hemostatic Agents and Tissue Sealants Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hemostatic Agents and Tissue Sealants Market Segment Percentages, by Application, 2021 (%)
Minimally Invasive Surgery
General Surgery
Others
Global Hemostatic Agents and Tissue Sealants Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hemostatic Agents and Tissue Sealants Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hemostatic Agents and Tissue Sealants revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Hemostatic Agents and Tissue Sealants revenues share in global market, 2021 (%)
Key companies Hemostatic Agents and Tissue Sealants sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Hemostatic Agents and Tissue Sealants sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
Baxter
C R Bard
B Braun
Gelita
Integra Life Sciences
Advance Medical Solution
Pfizer
CSL Behring
CryoLife
Zimmer Biomet
Ferrosan Medical Devices
Medtronic
Smith & Nephew
Z-Medica
Cohera Medical
Marine Polymer
Equimedical
This Report Addresses:
– Market Intelligence enables effective decision-making
– Market estimates and forecasts from 2022 to 2028
– Growth opportunities and trend analysis
– Segment and regional revenue forecast for market evaluation
– Competitive strategy and analysis of market segments
– List of product innovations to stay on top.
– The impact of COVID-19 and how to survive in these fast-growing markets.
1 Introduction to Research & Analysis Reports
1.1 Hemostatic Agents and Tissue Sealants Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hemostatic Agents and Tissue Sealants Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hemostatic Agents and Tissue Sealants Overall Market Size
2.1 Global Hemostatic Agents and Tissue Sealants Market Size: 2021 VS 2028
2.2 Global Hemostatic Agents and Tissue Sealants Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Hemostatic Agents and Tissue Sealants Sales: 2017-2028
3 Company Landscape
3.1 Top Hemostatic Agents and Tissue Sealants Players in Global Market
3.2 Top Global Hemostatic Agents and Tissue Sealants Companies Ranked by Revenue
3.3 Global Hemostatic Agents and Tissue Sealants Revenue by Companies
3.4 Global Hemostatic Agents and Tissue Sealants Sales by Companies
3.5 Global Hemostatic Agents and Tissue Sealants Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Hemostatic Agents and Tissue Sealants Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Hemostatic Agents and Tissue Sealants Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hemostatic Agents and Tissue Sealants Players in Global Market
3.8.1 List of Global Tier 1 Hemostatic Agents and Tissue Sealants Companies
3.8.2 List of Global Tier 2 and Tier 3 Hemostatic Agents and Tissue Sealants Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Hemostatic Agents and Tissue Sealants Market Size Markets, 2021 & 2028
4.1.2 Hemostasis Agents
4.1.3 Tissue Sealing Agents
4.2 By Type - Global Hemostatic Agents and Tissue Sealants Revenue & Forecasts
4.2.1 By Type - Global Hemostatic Agents and Tissue Sealants Revenue, 2017-2022
4.2.2 By Type - Global Hemostatic Agents and Tissue Sealants Revenue, 2023-2028
4.2.3 By Type - Global Hemostatic Agents and Tissue Sealants Revenue Market Share, 2017-2028
4.3 By Type - Global Hemostatic Agents and Tissue Sealants Sales & Forecasts
4.3.1 By Type - Global Hemostatic Agents and Tissue Sealants Sales, 2017-2022
4.3.2 By Type - Global Hemostatic Agents and Tissue Sealants Sales, 2023-2028
4.3.3 By Type - Global Hemostatic Agents and Tissue Sealants Sales Market Share, 2017-2028
4.4 By Type - Global Hemostatic Agents and Tissue Sealants Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Hemostatic Agents and Tissue Sealants Market Size, 2021 & 2028
5.1.2 Minimally Invasive Surgery
5.1.3 General Surgery
5.1.4 Others
5.2 By Application - Global Hemostatic Agents and Tissue Sealants Revenue & Forecasts
5.2.1 By Application - Global Hemostatic Agents and Tissue Sealants Revenue, 2017-2022
5.2.2 By Application - Global Hemostatic Agents and Tissue Sealants Revenue, 2023-2028
5.2.3 By Application - Global Hemostatic Agents and Tissue Sealants Revenue Market Share, 2017-2028
5.3 By Application - Global Hemostatic Agents and Tissue Sealants Sales & Forecasts
5.3.1 By Application - Global Hemostatic Agents and Tissue Sealants Sales, 2017-2022
5.3.2 By Application - Global Hemostatic Agents and Tissue Sealants Sales, 2023-2028
5.3.3 By Application - Global Hemostatic Agents and Tissue Sealants Sales Market Share, 2017-2028
5.4 By Application - Global Hemostatic Agents and Tissue Sealants Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Hemostatic Agents and Tissue Sealants Market Size, 2021 & 2028
6.2 By Region - Global Hemostatic Agents and Tissue Sealants Revenue & Forecasts
6.2.1 By Region - Global Hemostatic Agents and Tissue Sealants Revenue, 2017-2022
6.2.2 By Region - Global Hemostatic Agents and Tissue Sealants Revenue, 2023-2028
6.2.3 By Region - Global Hemostatic Agents and Tissue Sealants Revenue Market Share, 2017-2028
6.3 By Region - Global Hemostatic Agents and Tissue Sealants Sales & Forecasts
6.3.1 By Region - Global Hemostatic Agents and Tissue Sealants Sales, 2017-2022
6.3.2 By Region - Global Hemostatic Agents and Tissue Sealants Sales, 2023-2028
6.3.3 By Region - Global Hemostatic Agents and Tissue Sealants Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Hemostatic Agents and Tissue Sealants Revenue, 2017-2028
6.4.2 By Country - North America Hemostatic Agents and Tissue Sealants Sales, 2017-2028
6.4.3 US Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.4.4 Canada Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.4.5 Mexico Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Hemostatic Agents and Tissue Sealants Revenue, 2017-2028
6.5.2 By Country - Europe Hemostatic Agents and Tissue Sealants Sales, 2017-2028
6.5.3 Germany Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.5.4 France Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.5.5 U.K. Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.5.6 Italy Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.5.7 Russia Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.5.8 Nordic Countries Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.5.9 Benelux Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Hemostatic Agents and Tissue Sealants Revenue, 2017-2028
6.6.2 By Region - Asia Hemostatic Agents and Tissue Sealants Sales, 2017-2028
6.6.3 China Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.6.4 Japan Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.6.5 South Korea Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.6.6 Southeast Asia Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.6.7 India Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Hemostatic Agents and Tissue Sealants Revenue, 2017-2028
6.7.2 By Country - South America Hemostatic Agents and Tissue Sealants Sales, 2017-2028
6.7.3 Brazil Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.7.4 Argentina Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Hemostatic Agents and Tissue Sealants Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Hemostatic Agents and Tissue Sealants Sales, 2017-2028
6.8.3 Turkey Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.8.4 Israel Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.8.5 Saudi Arabia Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.8.6 UAE Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Corporate Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Hemostatic Agents and Tissue Sealants Major Product Offerings
7.1.4 Johnson & Johnson Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.1.5 Johnson & Johnson Key News
7.2 Baxter
7.2.1 Baxter Corporate Summary
7.2.2 Baxter Business Overview
7.2.3 Baxter Hemostatic Agents and Tissue Sealants Major Product Offerings
7.2.4 Baxter Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.2.5 Baxter Key News
7.3 C R Bard
7.3.1 C R Bard Corporate Summary
7.3.2 C R Bard Business Overview
7.3.3 C R Bard Hemostatic Agents and Tissue Sealants Major Product Offerings
7.3.4 C R Bard Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.3.5 C R Bard Key News
7.4 B Braun
7.4.1 B Braun Corporate Summary
7.4.2 B Braun Business Overview
7.4.3 B Braun Hemostatic Agents and Tissue Sealants Major Product Offerings
7.4.4 B Braun Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.4.5 B Braun Key News
7.5 Gelita
7.5.1 Gelita Corporate Summary
7.5.2 Gelita Business Overview
7.5.3 Gelita Hemostatic Agents and Tissue Sealants Major Product Offerings
7.5.4 Gelita Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.5.5 Gelita Key News
7.6 Integra Life Sciences
7.6.1 Integra Life Sciences Corporate Summary
7.6.2 Integra Life Sciences Business Overview
7.6.3 Integra Life Sciences Hemostatic Agents and Tissue Sealants Major Product Offerings
7.6.4 Integra Life Sciences Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.6.5 Integra Life Sciences Key News
7.7 Advance Medical Solution
7.7.1 Advance Medical Solution Corporate Summary
7.7.2 Advance Medical Solution Business Overview
7.7.3 Advance Medical Solution Hemostatic Agents and Tissue Sealants Major Product Offerings
7.7.4 Advance Medical Solution Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.7.5 Advance Medical Solution Key News
7.8 Pfizer
7.8.1 Pfizer Corporate Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Hemostatic Agents and Tissue Sealants Major Product Offerings
7.8.4 Pfizer Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.8.5 Pfizer Key News
7.9 CSL Behring
7.9.1 CSL Behring Corporate Summary
7.9.2 CSL Behring Business Overview
7.9.3 CSL Behring Hemostatic Agents and Tissue Sealants Major Product Offerings
7.9.4 CSL Behring Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.9.5 CSL Behring Key News
7.10 CryoLife
7.10.1 CryoLife Corporate Summary
7.10.2 CryoLife Business Overview
7.10.3 CryoLife Hemostatic Agents and Tissue Sealants Major Product Offerings
7.10.4 CryoLife Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.10.5 CryoLife Key News
7.11 Zimmer Biomet
7.11.1 Zimmer Biomet Corporate Summary
7.11.2 Zimmer Biomet Hemostatic Agents and Tissue Sealants Business Overview
7.11.3 Zimmer Biomet Hemostatic Agents and Tissue Sealants Major Product Offerings
7.11.4 Zimmer Biomet Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.11.5 Zimmer Biomet Key News
7.12 Ferrosan Medical Devices
7.12.1 Ferrosan Medical Devices Corporate Summary
7.12.2 Ferrosan Medical Devices Hemostatic Agents and Tissue Sealants Business Overview
7.12.3 Ferrosan Medical Devices Hemostatic Agents and Tissue Sealants Major Product Offerings
7.12.4 Ferrosan Medical Devices Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.12.5 Ferrosan Medical Devices Key News
7.13 Medtronic
7.13.1 Medtronic Corporate Summary
7.13.2 Medtronic Hemostatic Agents and Tissue Sealants Business Overview
7.13.3 Medtronic Hemostatic Agents and Tissue Sealants Major Product Offerings
7.13.4 Medtronic Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.13.5 Medtronic Key News
7.14 Smith & Nephew
7.14.1 Smith & Nephew Corporate Summary
7.14.2 Smith & Nephew Business Overview
7.14.3 Smith & Nephew Hemostatic Agents and Tissue Sealants Major Product Offerings
7.14.4 Smith & Nephew Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.14.5 Smith & Nephew Key News
7.15 Z-Medica
7.15.1 Z-Medica Corporate Summary
7.15.2 Z-Medica Business Overview
7.15.3 Z-Medica Hemostatic Agents and Tissue Sealants Major Product Offerings
7.15.4 Z-Medica Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.15.5 Z-Medica Key News
7.16 Cohera Medical
7.16.1 Cohera Medical Corporate Summary
7.16.2 Cohera Medical Business Overview
7.16.3 Cohera Medical Hemostatic Agents and Tissue Sealants Major Product Offerings
7.16.4 Cohera Medical Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.16.5 Cohera Medical Key News
7.17 Marine Polymer
7.17.1 Marine Polymer Corporate Summary
7.17.2 Marine Polymer Business Overview
7.17.3 Marine Polymer Hemostatic Agents and Tissue Sealants Major Product Offerings
7.17.4 Marine Polymer Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.17.5 Marine Polymer Key News
7.18 Equimedical
7.18.1 Equimedical Corporate Summary
7.18.2 Equimedical Business Overview
7.18.3 Equimedical Hemostatic Agents and Tissue Sealants Major Product Offerings
7.18.4 Equimedical Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.18.5 Equimedical Key News
8 Global Hemostatic Agents and Tissue Sealants Production Capacity, Analysis
8.1 Global Hemostatic Agents and Tissue Sealants Production Capacity, 2017-2028
8.2 Hemostatic Agents and Tissue Sealants Production Capacity of Key Manufacturers in Global Market
8.3 Global Hemostatic Agents and Tissue Sealants Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hemostatic Agents and Tissue Sealants Supply Chain Analysis
10.1 Hemostatic Agents and Tissue Sealants Industry Value Chain
10.2 Hemostatic Agents and Tissue Sealants Upstream Market
10.3 Hemostatic Agents and Tissue Sealants Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hemostatic Agents and Tissue Sealants Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Research Methodology:
Hemostatic Agents and Tissue Sealants Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|